Business Context and Reporting Period
Company: Bowhead Specialty Holdings Inc. (NYSE: BOW)
Filing Type: Form 8-K (Current Report)
Date of Report: August 2, 2026
Reporting Period: The filing primarily addresses a material definitive agreement entered into on August 2, 2026, and references financial results for the three months ended June 30, 2026, announced on August 3, 2026.
Key Financial Metrics and Transaction Terms
Merger Consideration: $34.00 per share in cash for each outstanding share of Common Stock.
Termination Fee: $35 million payable to Parent (American Family Mutual Insurance Company, S.I.) under specific termination scenarios.
Financial Results: The filing references a press release (Exhibit 99.1) containing results for the three months ended June 30, 2026, but does not explicitly state revenue, profit, cash flow, or margin figures within the text of this 8-K.
Debt and Liquidity: No specific debt or liquidity metrics are provided in this filing text.
Material Changes and Transaction Structure
- Acquisition: Bowhead Specialty Holdings Inc. has entered into an Agreement and Plan of Merger to be acquired by American Family Mutual Insurance Company, S.I. ("Parent").
- Structure: A wholly-owned subsidiary of Parent ("Merger Sub") will merge with and into Bowhead, with Bowhead surviving as a direct wholly-owned subsidiary of Parent.
- Equity Treatment:
- Common Stock: Converted to $34.00 cash per share.
- Vested RSUs: Converted to cash equal to the Merger Consideration.
- Unvested RSUs (Non-CEO): Assumed by Parent and converted to beneficial interest securities in a special escrow subaccount, subject to original vesting conditions.
- CEO Awards (RSUs/PSUs): Assumed by Parent and converted to escrow securities vesting on the first anniversary of the Effective Time, with accelerated vesting provisions for termination without Cause or for Good Reason.
- Warrants: The Common Stock Purchase Warrant issued to Parent on May 23, 2024, will terminate with no consideration payable.
Guidance, Outlook, Risks, and Contingencies
Outlook and Guidance: The Company will not host its previously scheduled earnings conference call for the quarter ended June 30, 2026, due to the announced Merger. No forward-looking financial guidance is provided in this text.
Conditions to Closing:
- Approval by a majority of outstanding shares and a majority of shares held by stockholders other than Parent and Recused Directors.
- Expiration of the HSR Act waiting period and receipt of regulatory approvals from insurance regulators in Wisconsin and Texas.
- Absence of laws or governmental orders prohibiting the Merger.
- No "Company Material Adverse Effect" or "Burdensome Condition."
Timeline:
- Outside Termination Date: April 2, 2027.
- Extension: May be extended to June 2, 2027 if delays are solely due to HSR or regulatory approvals.
Risks: Risks include failure to obtain stockholder or regulatory approval, interloper risk (Superior Proposal), disruption of management attention, and potential legal proceedings. The Board retains the right to change its recommendation or terminate the agreement to pursue a Superior Proposal, subject to paying the $35 million termination fee.
Investor Verification Checklist
- Verify the exact terms of the Merger Agreement in Exhibit 2.1, specifically regarding the definition of "Company Material Adverse Effect" and "Burdensome Condition."
- Review the upcoming Proxy Statement on Schedule 14A and the Schedule 13E-3 for detailed risk factors and financial analysis not included in this 8-K.
- Confirm the status of regulatory approvals required from Wisconsin and Texas insurance regulators.
- Examine the press release (Exhibit 99.1) for specific Q2 2026 financial results (revenue, earnings, etc.) which are referenced but not detailed in this filing.
- Monitor for any "Superior Proposal" that could trigger the Board's fiduciary out and the $35 million termination fee.